Ergoteles LLC Galapagos Nv Transaction History

Ergoteles LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$52.3 - $71.59 $104,652 - $143,251	2,001 Added 33.51%	7,972 $445,000
Q1 2022 May 13, 2022	BUY	$51.32 - $68.5 $306,431 - $409,013	5,971 New	5,971 $370,000
Q3 2021 Nov 15, 2021	SELL	$52.17 - $70.2 $640,021 - $861,213	-12,268 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$68.86 - $83.34 $1.4 Million - $1.7 Million	-20,386 Reduced 62.43%	12,268 $845,000
Q1 2021 May 12, 2021	BUY	$76.15 - $111.94 $2.49 Million - $3.66 Million	32,654 New	32,654 $2.52 Million

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.9B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.